This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina Healthcare (MOH) Offers $750M, 3.875% Senior Notes
by Zacks Equity Research
Molina Healthcare (MOH) shows discretion in issuing senior notes amid a low-interest rate environment, which in turn, will procure funds.
Encompass Health (EHC) Set to Widen Presence in South Carolina
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.
Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal
by Zacks Equity Research
Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.
Magellan (MGLN) Q3 Earnings Decline Y/Y on Elevated Costs
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results reflect impact of rising expenses, partly offset by top-line growth and net new business growth in the Healthcare segment.
Humana's (HUM) Earnings Beat Estimates in Q3, Surge Y/Y
by Zacks Equity Research
Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
MEDNAX's (MD) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
MEDNAX's (MD) third-quarter results reflect growing revenues driven by rising patient volumes, partly offset by higher general and administrative expenses.
4 Hospital Stocks to Gain From Rebounding Patient Volumes
by Zacks Equity Research
Expanding patient volumes, use of telehealth services, cost-control measures and an aging demography are tailwinds to the hospital industry players like HCA, UHS, THC and ACHC.
Community Health's (CYH) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from a solid revenue stream and lower expenses.
Molina Healthcare's (MOH) Q3 Earnings Beat Mark, Fall Y/Y
by Zacks Equity Research
Molina Healthcare (MOH) Q3 earnings gain from better revenues, partly offset by steep expenses.
Ensign Group (ENSG) Q3 Earnings Meet, '21 Earnings Guidance Up
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings gain from improved revenues, partly offset by steep expenses.
Teladoc Health (TDOC) Q3 Loss Narrower Than Expected, Down Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) third-quarter results indicate improved revenues owing to higher access fees and visit fees, partly offset by elevated costs.
Can Tenet (THC) Climb 25% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.3% upside potential for Tenet (THC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Universal Health (UHS) Q3 Earnings Miss Mark, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect high expenses, partly offset by better revenues.
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
by Srijita Guha
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings results reflect gains from patient volumes and better revenues.
Tenet Healthcare (THC) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Tenet Healthcare (THC) has been struggling lately, but the selling pressure may be coming to an end soon.
Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.
Tenet Healthcare (THC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 82.57% and 1.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Tenet Healthcare (THC) Ahead of Earnings?
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for UnitedHealth's (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to report a rise in earnings and revenues.
Down 14.9% in 4 Weeks, Here's Why Tenet (THC) Looks Ripe for a Turnaround
by Zacks Equity Research
Tenet (THC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Cigna (CI) Divests Unit to Chubb to Streamline Business
by Zacks Equity Research
Cigna (CI) sells its businesses to Chubb to focus on core growth areas.